Cargando…
Stratifying Risk for Pancreatic Cancer by Multiplexed Blood Test
SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease, and the currently available techniques for its detection are either invasive or less sensitive. To overcome this limitation, we present here a multiplexed point-of-care test that combines systemic inflammatory respon...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251844/ https://www.ncbi.nlm.nih.gov/pubmed/37296945 http://dx.doi.org/10.3390/cancers15112983 |